USPTO serial 99666334
IONIS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- TWAY, TATIANA R
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with IONIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brian J. Focarino
Brian J. Focarino Cooley LLP1299 Pennsylvania Avenue, NW, Suite 700IP Docketing DepartmentWashington, DC 20004-2400Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 044 | Medical and healthcare services; Providing medical information, healthcare information and medical information about pharmaceuticals, biologics and therapeutics; Providing healthcare and medical information regarding patient access to pharmaceuticals, biologics, and therapeutics, and safe and appropriate use and distribution of pharmaceuticals, biologics, and therapeutics; Provision of healthcare information relating to autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Healthcare services, namely, patient advisory, support and consultancy services relating to healthcare, pharmaceuticals, biologics and therapeutics; Healthcare services, namely, patient advisory, support and consultancy services regarding access to medical treatment of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Medical consulting services in the field of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Providing medical and healthcare information in the field of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Providing medical and healthcare information for healthcare professionals, caregivers, patients, and providers in the field of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Collecting medical and clinical data and information on autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders for treatment and diagnostic purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 25, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 25, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 19, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 27, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 1, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 1, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 1, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 1, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 22, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 21, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 23, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 23, 2026 | NWAP | NEW APPLICATION ENTERED | — |